Liver manifestations were more frequent in patients with ACVRL1 mutations, whereas manifestations of the skin and the GI-tract were seen equally distributed amongst HHT patients with ENG and ACVRL1 mutations. The gene discussed is ACVRL1; the disease is hereditary hemorrhagic telangiectasia.